Skip to content

A prospective cohort study on the prediction of comorbidities, therapeutic efficacy and side effects of systemic treatment of psoriasis by TCM constitution and multi-modal TCM information

A prospective cohort study on the prediction of comorbidities, therapeutic efficacy and side effects of systemic treatment of psoriasis by TCM constitution and multi-modal TCM information

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025002518
Enrollment
Unknown
Registered
2025-12-24
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriasis

Interventions

Psoriasis cohort:Not Applicable

Sponsors

The Second Affiliated Hospital of Hunan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patients diagnosed with psoriasis according to the Psoriasis Diagnosis and Treatment Guidelines (2023 Edition); (2) Patients aged 18 years or older; (3) Patients undergoing systemic treatment (including traditional systemic therapy, biologics and small molecule targeted drugs).

Exclusion criteria

Exclusion criteria: (1) Patients with other immune system disorders (including but not limited to rheumatoid arthritis, Crohn's disease, systemic lupus erythematosus, etc.); (2) Patients with incomplete personal information and without disease severity scores; (3) Patients with malignant tumors; (4) Patients with severe infections; (5) Patients with active tuberculosis.

Design outcomes

Primary

MeasureTime frame
Psoriasis Area and Severity Index 75%;Traditional Chinese Medicine Body Type Information;Traditional Chinese Medicine multimodal information;

Secondary

MeasureTime frame
The current treatment plan;complication;auxiliary examination;the patient reported outcomes;Psoriasis Area and Severity Index 90%;Psoriasis Area and Severity Index 100%;

Countries

China

Contacts

Public ContactWang Haizhen

The Second Affiliated Hospital of Hunan University of Chinese Medicine

491476160@qq.com13873165440

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jul 23, 2026